We are live on ! Find out more
OSRH

OSR Health

Delisted

OSRH was delisted on the 25th of August, 2026.

13 hedge funds and large institutions have $16.9M invested in OSR Health in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

20.75% more ownership

Funds ownership: 17.78%38.53% (+21%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

3% less capital invested

Capital invested by funds: $17.4M → $16.9M (-$470K)

13% less funds holding

Funds holding: 1513 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
13
Holders Change
-2
Holders Change %
-13.33%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
4
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change

OSRH Hedge Fund Activity: Q3 2024 in Review

13 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in OSR Health (OSRH) for Q3 2024, worth a combined $16.9M — down 2.7% from $17.4M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of OSRH and 0 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was Clear Street, adding an estimated $1.32M. The largest seller was Exos Asset Management, exiting entirely with an estimated $2.15M sold.

  • 13 institutional investors held OSR Health (OSRH) as of Q3 2024, down from 15 in Q2 2024.
  • Funds reported $16.9M of OSR Health stock for Q3 2024, down 2.7% quarter-over-quarter.
  • 0 funds opened new OSR Health positions in Q3 2024 and 2 closed out, a net change of -2 holders.
  • The largest OSR Health buyer in Q3 2024 was Clear Street, an estimated $1.32M added.
  • The largest OSR Health seller in Q3 2024 was Exos Asset Management, an estimated $2.15M sold.

Based on aggregated 13F filings for Q3 2024.